Meibomian Gland Dysfunction Treatment

Indiana University

Status: Completed

Conditions: Dry Eye; Meibomian Gland Dysfunction

Treatments: Device: Light Based (Sham) Treatment; Device: LipiFlow

Study type: Interventional

Funder types: Other

Identifiers

NCT04229888

1908329543

Details and patient eligibility

About

The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.

Enrollment: 14 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• evidence of meibomian gland obstruction in both eyes
• dry eye symptoms per DEQ-5

Exclusion criteria

• active ocular infection
• previous LipiFlow treatment
• beginning new oral or other systemic medications within prior 3 months
• beginning new or changing dosages of ocular medications within prior 3 months
• previous ocular surgery, trauma, herpes, recurrent inflammation, punctal plugs in prior 3 months
• habitual contact lens wear in prior 3 months
• women who are pregnant or nursing

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

14 participants in 1 patient group

Subject Treatment

Experimental group

Description:

All subjects will receive light based (sham) treatment, then all subjects will receive LipiFlow treatment.

Treatment:

Device: Light Based (Sham) Treatment

Device: LipiFlow